Olof Johnell Science Award
The IOF Olof Johnell Science Award, named in honour of the late Professor Olof Johnell, was presented for the first time in 2013 and has been awarded annually during the WCO-IOF-ESCEO Congress. The Award honours an individual who has contributed to the field of osteoporosis in a scientific or policy implementation area, worldwide. The candidates will be nominated by IOF members and the winner chosen by the IOF Board.
Professor Johnell achieved a wide breadth of knowledge in metabolic bone disease through a career that focused on basic research in the 1970s, clinical trials in the 1980s, epidemiology and health technology assessment in the 1990s, and health economics and guideline development in the later years of his life. He was sought out as a colleague or consultant worldwide and has contributed significantly to the scientific policies of the European Union, the International Osteoporosis Foundation, and the World Health Organization.
Dr Michael R. McClung, MD, FACP, FACE, is the Founding Director of the Oregon Osteoporosis Center in Portland, and an internationally recognized clinician, researcher, and educator in osteoporosis and metabolic bone diseases. A longstanding member of IOF's board, he was awarded the Olof Johnell Science Award in 2020 on the occasion of the WCO-IOF-ESCEO 2020.
Professor John A. Kanis, Prof. Emeritus Professor in Human Metabolism, and Director of the Centre for Metabolic Bone Diseases (formerly WHO Collaborating Centre), University of Sheffield, UK and Professorial Fellow at the Australian Catholic University, Melbourne, Australia. He is the Honorary President of the International Osteoporosis Foundation and Honorary President of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, among other positions. With his remarkable body of research, including in the area of health economics and policy implementation, Prof. Kanis is one of the field's most renowned and influential investigators.
Prof. Cyrus Cooper, Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Epidemiology at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, was named winner of the 2018 award at the WCO-IOF-ESCEO 2018 Congress in Krakow, Poland. As one the most distinguished investigators in the field, Prof. Cooper has made numerous outstanding contributions to musculoskeletal research that have increased knowledge about the early prevention of osteoporosis and related fractures. Through his dedicated leadership of IOF, he has shown immense personal commitment to advancing the field on all fronts – from science and policy, to global patient advocacy.
Professor Olivier Bruyère was presented with this prestigious award at a ceremony held at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Florence, Italy, March 2017.Olivier Bruyère is Professor of Clinical Epidemiology in the Department of Public Health, Epidemiology and Health Economics, Professor of Geriatrics Rehabilitation in the Department of Motricity Sciences, and Head, Support Unit, Epidemiology and Biostatistics, at the University of Liège, Belgium. His areas of interest include epidemiology, public health, health economics, pharmacoepidemiology, physiotherapy, sport and rehabilitation, quality of life, geriatrics, nutrition, economic evaluation of the prevention and treatment of osteoarthritis, osteoporosis and frailty.
Professor Serge Ferrari, Associate Professor of Medicine and Senior Consultant in Metabolic bone diseases at the Geneva University Hospital has been named winner of the International Osteoporosis Foundation’s 2016 Olof Johnell Science Award, presented during the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. As a thought leader in the field of bone health, Professor Ferrari has made notable contributions through outstanding research with a focus on the translation of new findings on the biological and pharmacological mechanisms of action on bone into improved patient care in osteoporosis and metabolic bone disorders.
The Award was presented to Professor Roger Fielding at the IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases in Milan, Italy. Prof. Fielding is Director and Senior Scientist of the Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. The Award is in recognition of his notable contributions to our understanding of the underlying mechanisms contributing to age-associated decline in skeletal muscle mass, the resultant impact on function, and the potential role of exercise, nutrition, and physical activity on attenuating this process.
Professor Jonathan D. Adachi M.D. was named the winner of the IOF 2014 Olof Johnell Science Award, presented on April 5, 2014 in Seville, Spain. Professor Adachi is Professor and Alliance for Better Bone Health Chair in Rheumatology at the Department of Medicine of McMaster University. As a thought-leader in the bone field, Prof. Adachi's epidemiological research and clinical studies have helped to advance knowledge of risk factors and therapies for osteoporosis. He has also made notable contributions to the development of clinical guidelines and is an internationally recognized speaker and advocate on behalf of osteoporosis.
Harry Genant, Professor Emeritus of the University of California San Francisco, was named the winner of first Olof Johnell Science Award, presented on April 18 during the .European Congress on Osteoporosis and Osteoarthritis (ECCEO13-IOF) in Rome, Italy. IOF General Secretary Professor Bess Dawson Hughes presented the award, stating, “Harry Genant is internationally renowned as a researcher, author and educator. His work in noninvasive and quantitative imaging methods for osteoporosis, arthritis and orthopaedics has been influential around the world, and he has made important contributions to clinical advances and the development of best practice guidelines.”